About: Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 07 September 2007

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у вересні 2007 (uk) article scientifique publié en 2007 (fr) im September 2007 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 07 September 2007 (en) artículu científicu espublizáu en setiembre de 2007 (ast)
publication date	wds:Q81152369-C7103B28-A1FC-45B9-855D-7627B23F271F
publication date	2007-09-07 00:00:00Z (xsd:dateTime)
author name string	wds:Q81152369-180A2568-5E72-4613-B311-77271083A367 wds:Q81152369-51E02CBF-0C83-44B9-99F8-E09294B545D1 wds:Q81152369-76CA1283-4000-4973-BFBB-DF8F4CC5FEBE wds:Q81152369-B0772124-8913-446E-A5E7-833CB3E1F9BE wds:Q81152369-B536C9D3-9471-412D-B456-A18BEE4D0837
author name string	Bilgin Ozmen Zeliha Hekimsoy Feyzullah Guclu Kadir Aydin Sabriye O Kafesciler
rdfs:label	Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis (en) Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis (nl)
skos:prefLabel	Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis (en) Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis (nl)
name	Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis (en) Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis (nl)
author	wds:Q81152369-A8236B6B-EDEA-44A5-B4A0-1346C5A0E1DF
author	Cengiz Kirmaz
title	wds:Q81152369-077664F7-C3B1-4F5C-9550-F13AA583D3D5
title	Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis (en)
page(s)	wds:Q81152369-A3FC77C3-6F62-4969-8429-10CB833702A9
page(s)	148-153
instance of	wds:Q81152369-E7B751D5-796A-468C-818D-FE6DBF3CDE8E
instance of	scholarly article
main subject	wds:Q81152369-8499C460-E561-40C6-80B2-D38C03226295 wds:Q81152369-E7F2C628-48B7-459C-894A-BE61A074971E
main subject	estrogen postmenopausal osteoporosis
PubMed ID	wds:Q81152369-98A57A3F-5F8F-494A-9B7B-565846ED7D66
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17823083
PubMed ID	17823083
published in	wds:Q81152369-9B0BE097-390B-4650-92CA-920867E85984
published in	European Cytokine Network
issue	wds:Q81152369-21465760-8A24-4C73-BA8E-B46A0EAC9748
volume	wds:Q81152369-26A195DD-C63A-4031-9FB7-4ED887050E68
issue	3
volume	18
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q81152369
is cites work of	Effect of kidney-reinforcing and marrow-beneficial traditional Chinese medicine-intervened serum on the proliferation and osteogenic differentiation of bone marrow stromal cells Modified Mediterranean Diet for Enrichment of Short Chain Fatty Acids: Potential Adjunctive Therapeutic to Target Immune and Metabolic Dysfunction in Schizophrenia? A clinical therapeutic protein drug-drug interaction study: coadministration of denosumab and midazolam in postmenopausal women with osteoporosis Chemopreventive efficacy of raloxifene, bexarotene, and their combination on the progression of chemically induced colon adenomas to adenocarcinomas in rats Long-term anti-arthritic and anti-osteoporotic effects of raloxifene in established experimental postmenopausal polyarthritis Neurocognitive, Neuroprotective, and Cardiometabolic Effects of Raloxifene: Potential for Improving Therapeutic Outcomes in Schizophrenia. Association of Adrenergic Receptor α2A (α2A-AR) Gene rs1800544 Polymorphism with Bone Mineral Density and Bone Turnover Markers in an Elderly Chinese Population.
is cites work of	wds:Q34585312-BC67BBAF-C3A0-40D5-908D-A3CD0D6D604A wds:Q37721268-6029E434-4409-4CBC-883B-42FA5679573B wds:Q36306224-80B5E754-553F-4414-8AB5-6896A46BF7F4 wds:Q46627659-9BB041FB-1F6A-4AC1-BF2F-80ED689BA721 wds:Q34286862-5E191C3A-CFE0-42F0-BEDD-B63DD2E7F16F wds:Q64895950-5C3C5170-D001-419A-A82A-831D512AEE57 wds:Q38837641-740AD5D6-FC86-45A1-B519-7C39A77F1065

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 194 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software